Phibro Anl Htlh A Cmn (PAHC) 25.86 $PAHC Phibro

Phibro Anl Htlh A Cmn (PAHC) 25.86 $PAHC

Phibro Animal Health (PAHC) Q4 Earnings Top, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 6:51AM CDT
Phibro's (PAHC) fiscal fourth-quarter bottom line comfortably exceeding the Zacks Consensus Estimate, while its revenues expanded in low-single-digit on a year-over-year basis.
GWPH: 82.73 (+0.45), PAHC: 25.86 (+0.27), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
GlobeNewswire - Mon Aug 29, 3:40PM CDT
Phibro Animal Health Corporation (NASDAQAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2016. It also provided guidance for its fiscal year ending June 30, 2017.
PAHC: 25.86 (+0.27)

Phibro Animal Health: Currency & Competition Woes Persist
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:33PM CDT
Phibro (PAHC) faces competition from generic alternatives of some of its products that may weigh on its future financial health and operational performance.
GWPH: 82.73 (+0.45), PAHC: 25.86 (+0.27), BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16)

Phibro Animal Health Corporation to Participate in the Credit Suisse 2016 Small and Mid Cap Conference
GlobeNewswire - Mon Aug 22, 5:00PM CDT
Phibro Animal Health Corporation (NASDAQAHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Credit Suisse 2016 Small and Mid Cap Conference.
PAHC: 25.86 (+0.27)

Phibro Animal Health Corporation to Participate in the Morgan Stanley 2016 Global Healthcare Conference
GlobeNewswire - Mon Aug 22, 5:00PM CDT
Phibro Animal Health Corporation (NASDAQAHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Morgan Stanley 2016 Global Healthcare Conference.
PAHC: 25.86 (+0.27), MS: 31.89 (-0.02)

Phibro (PAHC) Focuses on Growth Amid Pricing Pressure
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 9:30AM CDT
On Aug 16, 2016, we issued an updated research report on Phibro Animal Health Corporation (PAHC).
GWPH: 82.73 (+0.45), PAHC: 25.86 (+0.27), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)

Strategy To YieldBoost Phibro Animal Health Corp. From 2.2% To 11.5% Using Options
StockOptionsChannel.com - Tue Jun 28, 10:36AM CDT
Shareholders of Phibro Animal Health Corp. looking to boost their income beyond the stock's 2.2% annualized dividend yield can sell the December covered call at the $22.50 strike and collect the premium based on the 80 cents bid, which annualizes to...
PAHC: 25.86 (+0.27)

Velocity Increases the Value of Cloud Applications for Phibro Animal Health
Marketwire Canada - Tue Jun 07, 7:38AM CDT
VCAMP(TM) Platform Takes JD Edwards to the Cloud, Adding Analytics and Proactive Alerting to Increase Agility and Reduce Risk
PAHC: 25.86 (+0.27)

Oregon livestock company wins trade-secret injunction
Capital Press - Sun Jun 05, 2:56PM CDT
SALEM, Ore. (AP) — An Oregon livestock company has won an injunction against a former employee accused of stealing trade secrets to start his own company in China.
PAHC: 25.86 (+0.27)

Phibro Animal Health Corporation Announces Gerald Carlson Retirement, Larry Miller Promotion
GlobeNewswire - Tue May 31, 3:15PM CDT
Phibro Animal Health Corporation (NASDAQAHC) today announced that Gerald Carlson, Chief Operating Officer, will retire after 14 years with Phibro, effective July 1, 2016.
PAHC: 25.86 (+0.27)

Phibro Animal Health Corporation to Participate at the Macquarie Global Emerging Leaders Conference
GlobeNewswire - Fri May 20, 3:00PM CDT
Phibro Animal Health Corporation (NASDAQAHC) Chief Financial Officer Richard Johnson will address financial analysts and portfolio managers at the Macquarie Global Emerging Leaders Conference.
PAHC: 25.86 (+0.27)

Phibro Animal (PAHC) Misses Q3 Earnings on Low Revenues
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:00AM CDT
Phibro (PAHC) ended the fiscal third quarter on a disappointing note, with its bottom line lagging the Zacks Consensus Estimate by a solid margin and its revenues failing to expand on a year-over-year basis.
SRDX: 29.48 (+1.24), PAHC: 25.86 (+0.27), BAX: 46.28 (+0.10), LMAT: 18.35 (+0.59)

Phibro posts 3Q profit
Automated Insights - Mon May 09, 6:22PM CDT
TEANECK, N.J. (AP) _ Phibro Animal Health Corp. (PAHC) on Monday reported fiscal third-quarter profit of $18.6 million.
PAHC: 25.86 (+0.27)

Phibro Animal Health Corporation Reports Third Quarter
GlobeNewswire - Mon May 09, 3:15PM CDT
Phibro Animal Health Corporation (NASDAQAHC) today announced its financial results for its third quarter ended March 31, 2016.
PAHC: 25.86 (+0.27)

Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2016 Health Care Conference
GlobeNewswire - Wed Apr 13, 12:00PM CDT
Phibro Animal Health Corporation (NASDAQAHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Bank of America Merrill Lynch 2016 Health Care Conference.
PAHC: 25.86 (+0.27)

Phibro Animal Declines as FDA Moves to Revoke Mecadox
Zacks Equity Research - Zacks Investment Research - Mon Apr 11, 12:50PM CDT
A recent reexamination by the FDA has led the authority to question Phibro Animal Health Corporation's (PAHC) Mecadox drug's safety.
PAHC: 25.86 (+0.27), BAX: 46.28 (+0.10), LMAT: 18.35 (+0.59), OFIX: 45.39 (-0.13)

Phibro Animal Health Corporation Reiterates Safety of Mecadox(R)
GlobeNewswire - Fri Apr 08, 1:59PM CDT
(NASDAQAHC) Today, the Food and Drug Administration (FDA) issued a press release stating its intention to take the initial steps in the process to rescind its approval of Mecadox(R) (carbadox). Mecadox has been approved and sold in the United States for more than 40 years and is a widely-used treatment for controlling bacterial diseases including Salmonella and swine dysentery. Mecadox is not used in human medicine and the class of drug is not considered a medically important antimicrobial. The approved Mecadox label requires a 42-day withdrawal period pre-harvesting, and to date we have not seen any hazardous residues of carbadox being detected from pig meat treated in accordance with the approved label.
PAHC: 25.86 (+0.27)

Phibro: Animal Health Grows amid Competition from Generics
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 1:35PM CDT
On Apr 7, 2016, we issued an updated research report on New Jersey-based Phibro Animal Health (PAHC).
CAPR: 3.80 (+0.16), CSII: 24.69 (+0.24), PAHC: 25.86 (+0.27), BAX: 46.28 (+0.10)

Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2016 Quarterly Financial Results
GlobeNewswire - Wed Mar 30, 3:00PM CDT
Phibro Animal Health Corporation (NASDAQAHC) will host a webcast and conference call to review third quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Monday, May 9, 2016.
PAHC: 25.86 (+0.27)